Tate & Lyle PLC
2 August 2001
Date: Thursday 2 August 2001
Tate & Lyle PLC
Chairman's Annual General Meeting Statement
At the Annual General Meeting of Tate & Lyle PLC in London today, Sir David
Lees, Chairman, made the following statement on current trading:
At the announcement of the Group's results on 7th June I said that our
immediate priorities were to complete the disposals of Western Sugar and
Domino Sugar and to improve the performance of Amylum.
The sale of Western to the Rocky Mountain Sugar Growers Co-operative, also
announced on the 7th June, remains subject to the Co-operative completing
their financing arrangements.
The conditional sale of Domino Sugar announced last week is in line with the
assumptions made when the accounts for the year to 31 March 2001 were
finalised. Completion is conditional upon, inter alia, the buyers completing
their financing and US competition authority approval, which may take several
months.
The level of losses sustained in the first quarter of the financial year in US
sugar has been higher than in the comparative period to June 2000 and shows no
immediate signs of abating.
In most of the ongoing activities of the Group, including Amylum, underlying
trading in the first quarter of the financial year has been close to or has
exceeded plan. The main exception has been Staley's Citric Acid division,
where pricing levels have been adversely impacted by Asian imports. We have
intensified our cost reduction efforts, including the recently announced 40%
reduction in the workforce at our Mexican facility. Price increases at Staley
and Amylum announced on 6 February 2001 have had a beneficial impact on
results. Energy costs have stabilised, albeit at higher levels than in the
comparative period.
The profit before tax, exceptional items and goodwill amortisation of the
Group, excluding US sugar, for the first quarter was in line with the profit
in the comparative period.
In the outlook paragraph in my statement in the Annual Report I said that we
had reasons to view the current year with greater confidence. Given the
underlying trading to date and progress on strategic issues, that view remains
unchanged.
In conclusion, may I remind you of the three elements of our core strategy.
They are:
To continue to develop higher margin and higher growth carbohydrate-based
products, building on the Group's technology strengths in our global starch
business.
To continue to rationalise our portfolio of assets and ensure that all
retained assets produce acceptable returns. We will divest businesses that do
not contribute value creation or which no longer fit with the Group's
strategy.
To continue to drive out costs in our aim to become the low cost producer in
all the markets we serve.
Enquiries: Mark Robinson 020 7626 6525
Chris Fox (Press) 020 7626 6525 (office)
or 0780 1808 553 (mobile)
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.